Posted by BCI Staff on Tue, Nov 01, 2011
The Center for Human Genome Variation (CHGV) at Duke University School of Medicine has just received a $25M grant to lead a 5-year, international study to identify the genetic basis of human epilepsy. The grant was awarded as part of a genetics of epilepsy "Center without Walls" initiative funded by the National Institute of Neurological Diseases and Stroke (NINDS) to a team of leaders in epilepsy and human genetics from around the world. Heading that team is Dr. David Goldstein, who is a professor of Molecular Genetics & Microbiology, professor of Biology, and director of the CHGV at Duke.
Read More